Purchases and Sales Made in Q2 2024 in Axsome Therapeutics, Inc. (AXSM)
This table provides information about the institutional ownership of Axsome Therapeutics, Inc. (AXSM) during Q2 2024. The information is specifically focused on institutions that hold shares of Axsome Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-78.3K- 82.33% |
$5.14M - $6.3M
|
16.8K
$2.35M
|
|
|
Aug 14, 2024
Q2 2024
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-88K- 63.77% |
$5.78M - $7.08M
|
50K
$6.98M
|
|
|
Aug 12, 2024
Q2 2024
|
Eagle Asset Management Inc
St Petersburg, FL |
SELL
|
- |
-128K- 56.45% |
$8.4M - $10.3M
|
98.6K
$13.8M
|
|
|
Aug 09, 2024
Q2 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-143K- 58.19% |
$9.39M - $11.5M
|
103K
$14.3M
|
|
|
Aug 14, 2024
Q2 2024
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-169K- 24.65% |
$11.1M - $13.6M
|
517K
$72.2M
|
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-204K- 92.61% |
$13.4M - $16.4M
|
16.3K
$2.27M
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-255K- 44.18% |
$16.8M - $20.5M
|
322K
$45M
|
|
|
Aug 13, 2024
Q2 2024
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-317K- 95.23% |
$20.8M - $25.5M
|
15.9K
$2.22M
|
|
|
Aug 13, 2024
Q2 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-348K- 98.78% |
$22.9M - $28M
|
4.29K
$600K
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-390K- 34.14% |
$25.7M - $31.4M
|
753K
$105M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-622K- 65.89% |
$40.9M - $50.1M
|
322K
$45M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-622K- 65.89% |
$40.9M - $50.1M
|
322K
$45M
|
|
|
Aug 14, 2024
Q2 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-646K- 58.46% |
$42.5M - $52M
|
459K
$64.1M
|
|